Los mejores oncohematólogos del tratamiento de Leucemia linfoblástica aguda — TOP-73 médicos

• Se especializa en el tratamiento de la leucemia linfoblástica aguda (LLA) para niños.
• Los tratamientos incluyen quimioterapia, terapia dirigida y trasplante de médula ósea.
• La formación internacional incluye experiencia en Europa y Estados Unidos.
• Aclamado por avanzar en el trasplante de células madre hematopoyéticas pediátricas.
• Certificado por la junta en hematología y oncología pediátrica.
• Miembro activo de la Asociación Europea de Hematología, mejorando los estándares de tratamiento.
• Ofrece consultas en español e inglés, lo que potencialmente ayuda a una base de pacientes más amplia.

• Se especializa en el tratamiento de la leucemia linfoblástica aguda (LLA) en niños.
• Los tratamientos incluyen quimioterapia, trasplante de células madre y terapia dirigida.
• Formación internacional en USA en Weill Cornell Medicine y Memorial Sloan Kettering.
• Director del Laboratorio de Hematología Oncología y Tumores del Desarrollo del Hospital Infantil de Barcelona.
• Realiza consultas en línea para niños con leucemia linfoblástica aguda.
• Habla inglés y español, facilitando la comunicación internacional con el paciente.
• Miembro de la Sociedad Americana de Oncología Clínica; experiencia reconocida a nivel mundial.

Hematólogo-oncólogo pediátrico, especialista en trasplante de médula ósea

El Dr. Jacopo Peccatori es el Jefe del Departamento de Trasplante de Médula Ósea en el Instituto Científico San Raffaele y uno de los mejores médicos especialistas en linfoma. Ha estado en este puesto desde 2006 y ha escrito más de 70 estudios sobre trasplante alogénico de médula ósea, leucemia aguda y mieloma múltiple. Es licenciado en medicina general por la Universidad de Milán y tiene especialidades en medicina interna y hematología y es miembro de la Sociedad Europea de Trasplante de Sangre y Médula y del Grupo Italiano de Trasplante de Células Madre Hematopoyéticas y Terapias Celulares.

Assoc. Prof. Dr. Oğuzhan BABACAN completed his undergraduate, specialty and sub-specialty education at GATA Military Medical Faculty/Ankara. After becoming a specialist in Pediatrics, he worked in the field of Social Pediatrics for two years, where Healthy Baby Monitoring and vaccine follow-up were carried out. Then, she completed her subspecialty training in Pediatric Hematology and Oncology and continued her studies in the field of pediatric blood and cancer diseases. In addition to the treatment of children suffering from leukemia, lymphoma, solid tumors and other blood diseases, she has been working in the Bone Marrow Transplantation (Transplant) Unit for 13 years in Allogeneic (unrelated and intrafamilial), Autologous (from the patient himself) and Haploidentical (partially HLA compatible) hematopoietic stem cell transplantation. In 2018, he received the title of Associate Professor in the field of Pediatric Hematology and Oncology Science/Art.

MEDICAL AREAS OF INTEREST

Healthy baby follow-up and vaccinations

Lymph node enlargement

Pediatric patients with anemia (anemia)

Leukemia

Lymphoma

Bone Marrow Transplant

ITP

Thalassemias

Hemophiliacs

Solid tumors

Hemangioma

Childhood blood disorders

Children with frequent infections

Fever of unknown origin

Malnutrition in children

Dr. Toluy Özgümüş has graduated from Istanbul University, Cerrahpaşa Faculty of Medicine in 2008 and completed his internal medicine specialty training at Haydarpaşa Numune Training and Research Hospital between 2009 and 2013. He received his Hematology subspecialty training at Marmara University Hematology Department between 2014-2017; He performed his compulsory service at Kars Harakani State Hospital between 2017-2019. He worked at Sancaktepe Şehit Prof. Dr. Ilhan Varak Training and Research Hospital between 2019-2023.

He is experienced in the field of bleeding and coagulation disorders, especially coagulation disorders (thrombophilia), and has dealt with the diagnosis and treatment of more than 1000 patients. Since he worked in the pandemic hospital of the Anatolian side of Istanbul during the pandemic period, he has extensive experience in the hematological findings of Covid-19 infection and the management of Covid-19 infection in hematological diseases. Hundreds of patient experiences are available in the diagnosis of myeloproliferative diseases such as Polycythemia Vera and Essential Thrombocytosis, in their differentiation from blood cell elevations due to other frequently confused causes, and in their treatment. He has experience in the diagnosis and all treatment processes of rare hematological cancers such as multiple myeloma, acute and chronic leukemias, lymphomas and histiocytosis, as well as bone marrow transplantation.

MEDICAL INTERESTS 

Clotting Disorders (Thrombophilia)

Bleeding Disorders

Myeloproliferative Diseases

Anemias (Anemia)

Acute and Chronic Leukemias

lymphomas

Bone marrow transplantation

Assoc. Prof. Ali Eser received his medical education at Uludağ University Faculty of Medicine; He completed his internal medicine residency training at Istanbul Training and Research Hospital and his hematology residency training at Marmara University.

Afterward, he completed his compulsory service at Marmara University Hematology Clinic, firstly at Çanakkale University and then at Bezmialem Vakıf University. He served as a lecturer. After working as a hematology specialist and assistant physician in charge of the adult bone marrow transplant unit for 2 years at Hisar Intercontinental Hospital, he worked as a lecturer at Bezmialem Vakıf University and in the adult bone marrow transplant unit at Istanbul Yeniyüzyıl University, and finally for 1 year. He worked as the responsible physician of the adult bone marrow transplant unit at Liv Hospital Gaziantep Hospital for some time. He received the title of associate professor in March 2022.

Education

• Ege Faculty of Medicine 1978
• Specialization in Pediatrics 1982
• Subspecialty Pediatric Oncology 2002 (EU Faculty of Medicine)
• Pediatric Hematology and Oncology 2012 (EU Faculty of Medicine)
• Deputy Chief of Clinic 1988 Tepecik EAH
• Clinical Chief 1993 Tepecik EAH
• Associate Professorship 1995
• Professorship  2002
• Ege U. Faculty of Medicine, faculty member 1998 – 2022
• EU Faculty of Medicine Department of Pediatrics 2009-2018
• Member of Tepecik Education Planning and Coordination Board (1993-1998)
• SSI Tepecik Hospital Ethics Committee Chairman (1996-1998)
• Turkish Society of Pediatric Hematology "Bone Marrow Transplantation Working Group Co-Chair" (2002-2006)
• Turkish Society of Pediatric Hematology "Bone Marrow Transplantation Working Group" (2006-2008)
• Turkish Society of Pediatric Hematology - Responsible for Bone Marrow Transplantation "Online" Data Registry System 2007-ongoing.
• Ege University Regenerative Medicine and Stem Cell Commission Chairman, 2011-2021

Institutional Memberships

• Turkish Medical Association İzmir and Kocaeli Branch
• Turkish National Pediatric Association - İzmir
• European Group for Bone Marrow Transplantation (EBMT); Ege University Pediatric Bone Marrow Transplantation Unit was accredited by the European Group for Bone Marrow Transplantation (EBMT) in June 2007.
• Turkish Society of Pediatric Hematology - Board Member for two terms (2005-2009)
• Turkish Society of Hematology - Board Member for two terms (2001/2005)
• Turkish Pediatric Oncology Association
• Bone Marrow Transplantation Foundation (KITVAK) Member of the Board of Trustees

Units he is the founder of                        

1- SSI Tepecik Hospital Pediatric Oncology Clinic (1990) 
2- SSI Tepecik Hospital Pediatric Bone Marrow Transplantation Unit (1992) 
3- EU Faculty of Medicine Pediatric Bone Marrow Transplantation Unit (1998) 
4- FOUNDER of JOURNAL OF PEDIATRIC RESEARCH, 2014; SCI application was made in 2022.  

Transplantation units that he contributed to the establishment of                        

1. İzmir BUÇH EAH Pediatric Bone Marrow Transplantation Unit (2019) 
2. Ümraniye EAH Pediatric Bone Marrow Transplantation Unit (2020) 
3. Kanuni Sultan Süleyman EAH Pediatric Bone Marrow Transplantation Unit (2020) (Transferred to Çam Sakura EAH)

Awards

• Thrombotic parameters in bone marrow stem cell transplant patients, Pediatric Hematology Congress, Trabzon 2003
• CD133 Antigen in Stem Cell: Pediatric Hematology Congress 2005. Research award
• The role of Toll like receptors in febrile neutropenic patients, Best poster award. Turkish Hematology Congress 2008, Çeşme-İzmir
• National pediatric stem cell transplantation activity- Oral presentation second prize, Turkish Hematology Society Stem Cell Transplantation Congress, 2022, Antalya

Publications

Kansoy S. "Bone Marrow and Stem Cell Transplantation Child Health and Diseases, 1st edition, EU Faculty of Medicine Printing House, 1999, İzmir

Kansoy S. Bone marrow transplantation in Thalassemia Major III. Aegean Thalassemia Days Book, 2000, Izmir

Kansoy S. Pediatric KIT Center Standards in Turkey. Childhood Acute Leukemias, Antalya 2000: 73-5

Kansoy S. Late Side Effects in Children. Special issue of Bone Marrow Transplantation Journal of Turkish Clinics. 2003

Kansoy S. Stem Cell Applications in Bone Marrow and Stem Cell Transplantation. Pediatric Oncology Nursing Course Book, İzmir, 2005

Kansoy S. Cord Blood as a Stem Cell Source. Stem Cell Special Issue. Turkey Clinics, 2008

Kansoy S. Stem Cell Transplantation in Lymphomas. General Pediatrics Book, Ed. Prof.Dr.Enver Hasanoglu, 2009

Kansoy S, Aksoylar S. Bone Marrow Transplantation in Children. Pediatrics, 2014 and 2017

Kansoy S. Rhabdomyosarcoma. Pediatrics, 2014 and 2017

Kansoy S. Approach to the child with cancer according to clinical findings. Pediatrics, 2014 and 2017 

11. Çetingül N, S.Kansoy, M.Kantar. Oncological Diseases. Pediatrics (Ed. A. Cura), 641-672, Ege University Print house, İzmir, 1999.  (1.05 points)

Kansoy S, M.Kantar. Head, Face and Eye Examination. Pediatric Prosthetic Physical Examination and Symptom Information (Ed. A.Cura)

Kantar M. Metabolic Emergency Problems in Oncology. Oncologic Emergencies and Supportive Care in Childhood (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, İzmir, 2003. 

Cord Blood Transplants in Turkey. HEMATOLOGIST, 2016

Kansoy S. Central Nervous System Tumors in Children Pediatrics, 2014 and 2017

Acute myeloblastic leukemia in children and its treatment. Pediatric Oncology Textbook, Poplack's Turkish, 2020

National pediatric stem cell transplant activity, 2020

Childhood stem cell transplantation indications, Turkey Clinics - International book 2020

In addition to the studies and papers in international journals published in large numbers, he is involved in international multicenter studies in some journals with high impact value.

Oncohematólogo pediátrico, especialista en trasplante de médula ósea

Univ.-Prof. El Dr. Wolfgang Johannes Köstler es un especialista certificado por la junta en Medicina Interna, Hematología/Oncología y Medicina de Cuidados Intensivos que se especializa en hematología y oncología interna, medicina de cuidados intensivos. Es uno de los especialistas oncólogos mejor calificados en cáncer de mama y sarcoma y tiene una amplia experiencia en el campo y recibió títulos de la Universidad Médica de Viena y el Instituto de Ciencias Weizmann. También recibió capacitación especial en el Centro de Cáncer Memorial Sloan-Kettering y en el Hospital Royal Prince Alfred.

El Prof. Müge Gökçe es un hematólogo pediátrico y especialista en cáncer con sede en Turquía con experiencia en trasplante de médula ósea. Ha ocupado cargos en varios hospitales desde 2001 y tiene títulos en medicina general, pediatría y hematología y oncología pediátricas. Es miembro de la Asociación Turca de Hematología, la Sociedad Turca de Hematología Pediátrica y la Sociedad Europea de Trasplante de Sangre y Médula.

El Dr. Dror Levin es pediatra principal y director de los departamentos de tratamiento de trastornos sanguíneos y cáncer de huesos (sarcoma) en el Hospital Infantil "Dana" y el Centro Médico "Sourasky", respectivamente. Es especialista en medicina pediátrica, hematología y oncología, con experiencia adicional estudiando en el extranjero en el Instituto Ortopédico Rizzoli en Italia.

Oncólogo, oncohematólogo, especialista en trasplante de médula ósea

Educación

Facultad de Medicina: Universidad Ben Gurion

Especialización

• Medicina Interna - en el Centro Médico Sapir - Kfar Saba
• Hematología - Centro Médico Sourasky Tel Aviv

Experiencia Reconocido

Medicina Interna y Hematología

Educación adicional

NHLBI/NIH, Bethesda, EE. UU.

Experiencia clínica

• Médico senior del sistema hematológico de 2004 a 2006, 2008
• Director de la Clínica de Hematología de 2010 a 2014, 2017
• Gerente de Servicio CLL de 2013 a 2018
• Director del bloque CLL a partir de 2018
• Secretario del Grupo CLL de Israel desde 2016.

Experiencia academica

• Profesor Titular de Hematología - Universidad de Tel Aviv (2013-2018)
• Profesor Asociado de Hematología - Universidad de Tel Aviv (2018)

Publicaciones profesionales

Más de 80 publicaciones profesionales

Membresía de la unión

• Asociación Hematológica Israelí
• Asociación Americana de Hematología

Zonas de especial interés y actividades

Tratamiento e investigación en LLC

Undergraduate and Doctoral Education:

* 1992-1999 Ondokuz Mayıs University Faculty of Medicine

* 2002-2007 Inonu University, Faculty of Medicine, Child Health and Diseases,

Pediatrics Residency

* 2015-2018 Inonu University, Faculty of Medicine, Pediatrics, Pediatric

Hematology and Oncology Subspecialization

*2017-Ankara University, Pediatrics, Oncology minor residency (8 months)